SLC5A2 and aortic stenosis: Similarly, in a separate study, the same group showed that among diabetic patients with aortic stenosis undergoing transcatheter aortic valve implantation, treatment with SGLT2 inhibitors was associated with enhanced LV recovery and improved clinical outcomes [20].